Treatment Change as a Predictor of Outcome among Patients with Classic Chronic Graft-versus-Host Disease

Biology of Blood and Marrow Transplantation

Volumn 14, Issue 12, 2008, Pages 1380-1384

  Flowers, Mary E D ^a   Storer, Barry ^a   Carpenter, Paul ^a   Rezvani, Andrew R ^a   Vigorito, Afonso C ^b   Campregher, Paulo V ^a   Moravec, Carina ^a   Kiem, Hans Peter ^a   Fero, Matthew ^a   Georges, George ^a   Warren, Edus ^a   Lee, Stephanie ^a   Sanders, Jean E ^a   Appelbaum, Fred ^a   Martin, Paul J ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Chronic graft versus host disease; GVHD

Indexed keywords

PREDNISONE;

ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; DISEASE EXACERBATION; DRUG DOSE INCREASE; GRAFT SURVIVAL; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MORTALITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; THERAPY DELAY; TREATMENT PLANNING;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; GRAFT VS HOST DISEASE; HUMANS; INCIDENCE; INFANT; MALE; MIDDLE AGED; STEM CELL TRANSPLANTATION; SURVIVAL RATE;

EID: 56549114909     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2008.09.017     Document Type: Article

References (14)

1. Duell T., Van Lint M.T., Ljungman P., et al. Health and functional status of long-term survivors of bone marrow transplantation. EBMT Working Party on Late Effects and EULEP Study Group on Late Effects. Ann Intern Med 126 (1997) 184-192
2. Socie G., Stone J.V., Wingard J.R., et al. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. N Engl J Med 341 (1999) 14-21
3. Syrjala K.L., Chapko M.K., Vitaliano P.P., Cummings C., and Sullivan K.M. Recovery after allogeneic marrow transplantation: prospective study of predictors of long-term physical and psychosocial functioning. Bone Marrow Transplant 11 (1993) 319-327
4. Goerner M., Gooley T., Flowers M.E.D., et al. Morbidity and mortality of chronic GVHD after hematopoietic stem cell transplantation from HLA-identical siblings for patients with aplastic or refractory anemias. Biol Blood Marrow Transplant 8 (2002) 47-56
5. Lee S.J., Vogelsang G., and Flowers M.E.D. Chronic graft-versus-host disease. Biol Blood Marrow Transplant 9 (2003) 215-233
6. Storek J., Dawson M.A., Storer B., et al. Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. Blood 97 (2001) 3380-3389
7. Stewart B.L., Storer B., Storek J., et al. Duration of immunosuppressive treatment for chronic graft-versus-host disease. Blood 104 (2004) 3501-3506
8. Martin P.J. Study design and endpoints in graft-versus-host disease. Best Practice Res Clin Haematol 21 (2008) 357-372
9. Martin P.J., Weisdorf D., Przepiorka D., et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: VI. Design of Clinical Trials Working Group report. Biol Blood Marrow Transplant 12 (2006) 491-505
10. Pavletic S., Martin P., Lee S.J., et al. Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. Response Criteria Working Group report. Biol Blood Marrow Transplant 12 (2006) 252-266
11. Kim D.H., Sohn S.K., Baek J.H., et al. Time to first flare-up episode of GVHD can stratify patients according to their prognosis during clinical course of progressive- or quiescent-type chronic GVHD. Bone Marrow Transplant 40 (2007) 779-784
12. Filipovich A.H., Weisdorf D., Pavletic S., et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and Staging Working Group report. Biol Blood Marrow Transplant 11 (2005) 945-956
13. Gooley T.A., Leisenring W., Crowley J., and Storer B.E. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 18 (1999) 695-706
14. Lee J.H., Lee J.H., Choi S.J., et al. Graft-versus-host disease (GVHD)-specific survival and duration of systemic immunosuppressive treatment in patients who developed chronic GVHD following allogeneic haematopoietic cell transplantation. Br J Haematol 122 (2003) 637-644